Cornerstone Planning Group
VIR icon

Cornerstone Planning Group’s Vir Biotechnology VIR Stock Holding History

Cornerstone Planning Group’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-100
Closed -$935 – 1652
2026
Q2 		$935 Hold
100
– – ﹤0.01% 1526
2026
Q1 		$1K Hold
100
– – ﹤0.01% 1462
2025
Q4 		$757 Buy
100
+87
+669% +$518 ﹤0.01% 1407
2025
Q3 		$450 Sell
13
-87
-87% -$445 ﹤0.01% 1505
2025
Q2 		$511 Hold
100
– – ﹤0.01% 1295
2025
Q1 		$597 Hold
100
– – ﹤0.01% 1250
2024
Q4 		$1.03K Hold
100
– – ﹤0.01% 946
2024
Q3 		$761 Hold
100
– – ﹤0.01% 1002
2024
Q2 		$865 Hold
100
– – ﹤0.01% 973
2024
Q1 		$1.04K Hold
100
– – ﹤0.01% 779
2023
Q4 		$1.01K Hold
100
– – ﹤0.01% 715
2023
Q3 		$937 Hold
100
– – ﹤0.01% 799
2023
Q2 		$2.45K Buy
+100
New +$2.51K ﹤0.01% 1099
2022
Q4 		$2.69K Buy
+100
New +$2.45K ﹤0.01% 1113

Other funds holding VIR

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Atria Investments
Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return
Foster Group
Foster Group West Des Moines, Iowa $3.68B AUM 13.84% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.34% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Cornerstone Planning Group's VIR Position: Q3 2026 in Review

Cornerstone Planning Group sold out of Vir Biotechnology (VIR) in Q3 2026, closing a stake of 100 shares — an estimated $935 sold.

Cornerstone Planning Group first reported a position in VIR in Q4 2022 and held it in 14 quarters. The position peaked at $2.69K in Q4 2022. 24 funds tracked by Wall St. Rank hold VIR as of Q3 2026.

  • Cornerstone Planning Group reported no remaining Vir Biotechnology position as of Q3 2026 after selling out during the quarter.
  • Cornerstone Planning Group sold 100 Vir Biotechnology shares in Q3 2026, an estimated $935.
  • Cornerstone Planning Group first reported a position in Vir Biotechnology in Q4 2022 and held it in 14 quarters.
  • Cornerstone Planning Group's Vir Biotechnology position peaked at $2.69K in Q4 2022.
  • 24 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.

Based on Cornerstone Planning Group's 13F filing for Q3 2026, filed 16 Oct 2026.